论文部分内容阅读
我们用微粒子酶免包被法 ,动态测定各类型病毒性肝炎患者的血清 AFP及其他生化指标 ,并与原发性肝癌对照 ,以评估病毒性肝炎尤其是重型肝炎的疗效及预后 ,并寻找鉴别癌性与非癌性 AFP的相关因素。研究结果报告如下。1 临床资料1.1 病例选择 肝癌病例为 1996年 7月～ 1999年1
We use microparticle enzyme immunoassay, dynamic determination of serum AFP and other biochemical indicators of patients with various types of viral hepatitis, and with primary liver cancer control, in order to assess the efficacy and prognosis of viral hepatitis, especially severe hepatitis, and find the identification Relevant factors of cancerous and non-cancerous AFP. The results are reported as follows. 1 Clinical data 1.1 Case Selection Liver cancer cases from July 1996 to 1999 1